If you would like more information about the profile please click
. You will be directed to a new page where you will need
to provide some information about yourself/your business cooperation needs and submit
your expression of interest in the profile . A Network Partner will then contact
you to discuss your interest in greater detail.
A mechatronic Italian SME implemented and patented a technology based on phase inversion and developed a “spray machine” tested to produce biocompatible patches for tissues regeneration and heart valves having polymeric base. Company search pharmaceutical industries interested to develop new medical products using spray technology, research centres to study biomaterials and health structures for clinical trials. Technical and research cooperation agreements are proposed.
The applicant is an Engineering Italian company founded in 1991 as University spin off. Company is skilled to design and develop mechatronics products and robotic systems for industrial customers and as partner on R&D EU and National projects. The company is part of a US medium-sized Group producing and selling industrial and medical equipments on the global markets.
The company, in collaboration with an Italian Research Centre skilled in biomaterials, has developed and patented a technology, based on phase inversion, and a “spray machine” advanced prototype that allows to manufacture biocompatible pharmaceutical products for regeneration of tissues (eg patches for the treatment of ulcerative sores). A subsequent version of the spray machine prototype (also patented) has been set up with a robotic arm, which allows to manufacture three-dimensional medical prostheses (for example heart valves) with a polymeric base with modular physical and mechanical properties depending on the end use. The spray machine have two spray-guns that spray the polymeric solution and a non-solvent material focusing the jets in a precise point of the spindle (if a bi-dimensional patch is to be made) or on a mould model (if a shape is to be made three-dimensional such as a heart valve).
Markets target: medical applications for therapy of the ulcerative diabetic sores and application for dentistry.
Applicant company can study, implement and industrialize the customized manufacturing solutions for new medical products for tissue regeneration defined by the health and industrial partners
The company can also involve in the project the Italian biomaterial R&D Centre Research Centre that has already collaborated to the spray technology develop and testing. This R&D Centre is able to define, implement and test the new biomaterial requirements.
The company offers research cooperation agreements to University Laboratories and Research Centre to study and develop the biomaterials.
Medium and big Pharmaceutical and dentistry devices companies are sought to collaborate with technical agreements in the new products prototyping, developing, production and commercialization.
The company seeks also for Hospitals Health and Dentistry structures to implement the clinical trials with research cooperation agreements.
The spray machine uses the phase inversion technology to create three-dimensional polymer-based constructs, with physical and mechanical properties that can be modulated according to the end use. This system allows to spray at the same time a polymeric solution and a non-solvent focusing the jets in a precise point. Phase inversion technique allows to generate complex three-dimensional structures starting from polymeric solutions thermodynamically unstable and sprayed through two spray-guns.
The three-dimensional structure generated, similar to a "non-woven fabric", can assume different porosities, properties and morphological characteristics depending on the regulation of the manufacturing parameters.
The nanostructured patch developed by spray technology has been tested as device delivering drug of the growth factors contained in the platelet concentrate. Therapeutic efficacy has been verified “in vivo” on chronic sores of diabetic mouses.
The spray technology and machine are in use at a Biomaterial Centre for laboratory tests
Medium and big Pharmaceutical and dentistry devices companies to collaborate in new products prototype develop and produce and commercialize the news products resulting from the project.
The type of partnership considered is technical agreement.
University Laboratories and Research Centre to study and develop the biomaterials in collaboration also with the Italian Centre yet involved by applicant company. The partnership considered is research cooperation agreement.
Hospitals, Health and Dentistry structures to implement the clinical trials. Suggested partnership is research cooperation agreement.
Company staff is composed by around 25 people, including mechanical engineers, electronic engineers, software engineers, skilled technicians, marketing specialists and sales representatives.
Highly qualified personnel is the company strength that allow to offer very competitive industrial services relating the contract design and prototype development on the international markets.
The company participated since the 90s in more national and European R&D projects and worked with leading companies in the biomedical sector, automotive, gas & oil, rail transport.